CHADS2和CHA2DS2-VASc评分卒中与隐源性脑卒中患者功能预后的相关性研究

doi:10.19854/j.cnki.1008-2425.2024.04.0007

摘要/Abstract

摘要： 目的探讨房颤脑卒中风险评分(CHADS₂)和房颤脑卒中风险综合评分(CHA2DS₂-VASc)评分卒中与隐源性脑卒中(cryptogenic stroke,CS)患者功能预后的相关性研究。方法选择2021年1月至2023年10月与我院就诊的150例CS患者为研究对象,采用改良Rankin量表(modified Rankin Scale,mRS)评定患者的预后,将患者分为预后良好组(n=82)和预后不良组(n=68),比较两组患者的一般资料以及两组患者入院前的CHADS₂和CHA2DS₂-VASc评分。采用受试者工作特征(receiver operating characteristic,ROC)评估CHADS₂和CHA2DS₂-VASc评分对CS患者发生预后不良的预测价值。多因素Logistic回归分析CS患者预后不良的危险因素,建立风险评估量表并进行验证。Logistic回归模型分析CHADS₂和CHA2DS₂-VASc评分与CS患者预后不良的关系。结果与预后良好组患者相比,预后不良组心力衰竭、卒中史患者比例、入院国立卫生研究院卒中量表(National Institute of Health stroke scale,NIHSS)评分、血清肌酐(serumcreatinine,Scr)、脑钠肽(brain natriuretic peptide,BNP)、尿酸、CHADS₂和CHA2DS₂-VASc评分更高,而左心室射血分数(left ventricular ejection fraction,LVEF)水平更低(P＜0.05);校正混杂因素后,CHADS₂、CHA2DS₂-VASc与CS患者预后不良呈正相关;亚组分析显示CHADS₂、CHA2DS₂-VASc较高的患者,其CHADS₂、CHA2DS₂-VASc与CS患者预后不良相关性更明显(P_交互=0.010、0.008);多因素Logistic回归分析显示,心力衰竭、卒中史、CHADS₂、CHA2DS₂-VASc、入院NIHSS评分、BNP水平升高、LVEF水平降低均为预后不良发生的危险因素(P＜0.05);CHADS₂和CHA2DS₂-VASc评分对CS患者发生预后不良的预测效能良好。且两者联合预测预后不良,预测效能更高;选取0.5分作为预后不良的最佳预测界值,其灵敏度和特异性分别为74.75 %和70.28 %,≤1.5分预后不良风险为低危,2~2.5分为中危,≥3.5分为高危。使用其余100例病例对量表进行验证,灵敏度为79.32 %,特异性为78.85 %,阳性预测值为70.22 %,阴性预测值为85.64 %。结论对于CS患者CHADS₂和CHA2DS₂-VASc评分对患者预后不良具有预测价值,且两者联合预测CS患者预后,预测效能更高。

关键词: CHADS₂, CHA2DS₂-VASc, 预后, 隐源性脑卒中

Abstract: Objective To investigate the correlation between stroke and functional prognosis of patients with cryptogenic stroke (CS) by atrial fibrillation Stroke Risk score (CHADS₂) and atrial fibrillation Stroke risk comprehensive score (CHA2DS2-VASc). Methods 150 patients with CS who came to our hospital from January 2021 to October 2023 were selected as the study objects.The modified Rankin Scale (mRS) was used to evaluate the prognosis of the patients,and the patients were divided into good prognosis group (n=82) and poor prognosis group (n=68).General data and CHADS₂ and CHA2DS₂-VASc scores before admission were compared between the two groups.Receiver operating characteristic (ROC) was used to evaluate the predictive value of CHADS₂ and CHA2DS₂-VASc scores in patients with CS.The risk factors of poor prognosis in CS patients were analyzed by multivariate Logistic regression,and the risk assessment scale was established and verified.Logistic regression model was used to analyze the relationship between CHADS₂ and CHA2DS₂-VASc scores and poor prognosis in CS patients. Results Compared with patients in the good prognosis group,the proportion of patients with heart failure,stroke history,admission to the National Institute of Health stroke scale (NIHSS) score,serumcreatinine (serumcreatinine,Serumcreatinine) in the poor prognosis group was higher than that in the good prognosis group.Scr),brain natriuretic peptide (BNP),uric acid,CHADS₂ and CHA2DS₂-VASc scores were higher,while left ventricular ejection fraction,LVEF levels were lower (P＜0.05);After adjusting for confounding factors,CHADS₂ and CHA2DS₂-VASc were positively correlated with poor prognosis in CS patients.Subgroup analysis showed that patients with higher CHADS₂ and CHA2DS₂-VASc were more significantly associated with poor prognosis in CS patients (P interaction =0.010,0.008).Multivariate Logistic regression analysis showed that heart failure,stroke history,CHADS₂,CHA2DS2-VASC,NIHSS score on admission,increased BNP level and decreased LVEF level were all risk factors for poor prognosis (P＜0.05).CHADS₂ and CHA2DS₂-VASc scores were effective in predicting poor prognosis in CS patients.And the combination of the two predicted the prognosis was poor and the prediction efficiency was higher.The sensitivity and specificity of 0.5 points were 74.75% and 70.28%,respectively,and the risk of poor prognosis was defined as low risk,2-2.5 as medium risk,and ≥3.5 as high risk.The remaining 100 cases were used to verify the scale.The sensitivity was 79.32 %,the specificity was 78.85 %,the positive predictive value was 70.22 %,and the negative predictive value was 85.64 %. Conclusion For CS patients,CHADS₂ and CHA2DS₂-VASc scores have predictive value for patients with poor prognosis,and the combination of the two can predict the prognosis of CS patients with higher predictive efficacy.

Key words: CHADS₂, CHA2DS2-VASc, Prognosis, Cryptogenic stroke

中图分类号:

R743

张爱娣, 吴纪霞, 司峥, 陈栋肖. CHADS₂和CHA2DS₂-VASc评分卒中与隐源性脑卒中患者功能预后的相关性研究[J]. 立体定向和功能性神经外科杂志, 2024, 37(4): 227-234.

Zhang Aidi, Wu Jixia, Si Zheng, Chen Dongxiao. Correlation between CHADS₂ and CHA2DS₂-VASc scores and functional outcomes in patients with cryptogenic stroke[J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2024, 37(4): 227-234.

参考文献

[1] 杨燕玲,严可,李亚文,等.CHA2DS2-VASc评分预测非房颤人群首发缺血性脑卒中幸存者复发风险的效果评价[J].南方医科大学学报,2020,40(6):786~792.
[2] 武德崴,王宇彬,李博宇,等.经皮左心耳封堵术在心房颤动合并缺血性脑卒中或短暂性脑缺血发作恢复期患者中的安全性和有效性研究[J].中国循环杂志,2022,37(12):1208~1213.
[3] Kusznir Vitturi B,Jose Gagliardi R.Use of CHADS₂ and CHA2DS₂-VASc scores to predict prognosis after stroke[J].Rev Neurol (Paris),2020,176(1/2):85~91.
[4] Ukaji T,Ishikawa T,Nakamura H,et al.Prognostic impacts of CHADS₂,CHA2DS2-VASc,and CHA2DS2-VASc-HS scores on clinical outcomes after elective drug-eluting stent placement for de novo coronary stenosis[J].Circ Rep,2023,5(4):123~132.
[5] Jastrzbski M,Stec J,Fijorek K,et al.CHADS₂ and CHA2DS₂-VASc scores as tools for long-term mortality prognosis in patients with typical atrial flutter after catheter ablation[J].Kardiol Pol,2020,78(1):59~64.
[6] 孟心怡,吕敬雷,周杰,等.脑小血管病总体负担与房颤相关性卒中患者认知障碍的关系[J].中风与神经疾病杂志,2021,38(4):301~305.
[7] 来津,李孝明,方良勤,等.CHA2DS2-VASc评分在老年髋部骨折伴非瓣膜性心房颤动患者围手术期抗凝中的应用[J].第二军医大学学报,2021,42(7):818~822.
[8] Nam K,Kim C,Yu S,et al.Pre-Admission CHADS₂ and CHA2DS₂-VASc scores on early neurological worsening[J].Cerebrovasc Dis (Basel,Switzerland),2021,50(3):288~295.
[9] Chi NY,Su HM,Lee WH,et al.Using CHADS₂,R2 CHADS₂,CHA2DS₂ -VASc score for mortality prediction in patients with abnormal low and high ankle-brachial index[J].Int J Med Sci,2021,18(1):276~283.
[10] Yilmaz S,Yaylali YT,Kuyumcu MS,et al.Relationship between CHA2DS₂-VASc and CHADS₂ scores with pulmonary hypertension in patients with acute pulmonary embolism[J].Adv Respir Med,2019,87(6):203~208.
[11] Cao M,Guo H,Zhao X,et al.Refinement of CHADS₂ and CHA2DS₂-VASc scores predict left atrial thrombus or spontaneous echo contrast in nonvalvular atrial fibrillation patients:[J].J Int Med Res,2022,50(1):13~17.
[12] 杨红,刘俊,冯志刚,等.CHA2DS₂-VASc评分法筛查社区老年人群心房颤动与缺血性卒中患病情况的价值研究[J].中国全科医学,2021,24(18):2281~2284.
[13] 黄锐,雷玉华,赵劲波,等.首诊非瓣膜性心房颤动患者E/e′及颈动脉粥样硬化斑块与缺血性脑卒中的关系[J].华中科技大学学报(医学版),2021,50(5):632~639.
[14] Lin TC,Su HM,Lee WH,et al.CHA2DS₂-VASc score and risk of new-onset peripheral arterial occlusive disease in patients without atrial fibrillation[J].Acta Cardiol Sin,2021,37(3):261~268.
[15] Gonuguntla K,Rojulpote C,Patil S,et al.Utilization of NaF-PET/CT in assessing global cardiovascular calcification using CHADS₂ and CHADS₂-VASc scoring systems in high risk individuals for cardiovascular disease[J].Am J Nucl Med Mol Imaging,2020,10(6):293~300.
[16] 邱雪,薛素芳,宋海庆.急性缺血性卒中合并非瓣膜性心房颤动患者出院时口服抗凝药使用情况及其影响因素分析[J].中国脑血管病杂志,2021,18(11):753~764.
[17] Zheng N,Zhang J.External validation and comparison of CHA2DS2-VASc-RAF and CHA2DS2-VASc-LAF scores for predicting left atrial thrombus and spontaneous echo contrast in patients with non-valvular atrial fibrillation[J].J Interv Card Electrophysiol,2022,65(2):535~542.
[18] Mekhryakov SA,Kulesh AA,Pokalenko E A,et al.The paradoxical embolism phenomenon in patients with embolic cryptogenic stroke[J].Neurol Neuropsychiatry Psychosom,2020,12(1):13~21.
[19] Bah A,Nuotio I,Palomki A,et al.Inadequate oral anticoagulation with warfarin in women with cerebrovascular event and history of atrial fibrillation:the FibStroke study[J].Ann Med,2021,53(1):287~294.
[20] Lahad K,Maor E,Klempfner R,et al.CHA2DS₂-VASc score predicts the risk of stroke in patients hospitalized to the internal medicine department without known atrial fibrillation[J].J Gen Intern Med,2022,37(13):3355~3360.
[21] Sanchez Fernandez JJ,Ortiz,MR,Ballesteros FM,et al.CHA2DS₂-VASc score as predictor of stroke and all-cause death in stable ischaemic heart disease patients without atrial fibrillation[J].J Neurol,2020,267(10):3061~3068.
[22] Okubo A,Doi T,Morii K,et al.Utility of CHA2DS₂-VASc score to predict mid-term clinical outcomes in hemodialysis patients[J].Am J Nephrol,2022,53(2-3):169~175.
[23] Sulzgruber P,Doehner W,Niessner A.Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS₂-VASc score of 1- a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke corrected[J].Eur Heart J,2021,42(5):541~543.
[24] Pravda MS,Hagai KC,Topaz G,et al.Assessment of the CHA2DS₂-VASc score in predicting mortality and adverse cardiovascular outcomes of patients on hemodialysis[J].Am J Nephrol,2020,51(8):635~640.
[25] Yasar E,Bayramoğlu A,Karakus Y,et al.The CHA2DS₂-VASc risk score predicts total occlusion in infarct-related arteries in patients with Non-ST elevation myocardial infarction:[J].Angiology,2022,73(4):380~386.

CHADS₂和CHA2DS₂-VASc评分卒中与隐源性脑卒中患者功能预后的相关性研究

Correlation between CHADS₂ and CHA2DS₂-VASc scores and functional outcomes in patients with cryptogenic stroke

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	胥露, 宋敏, 刘佳, 陈真敏, 沈丹浥, 郑威. 高血压脑出血患者血小板活化指标变化规律及其与预后的相关性分析[J]. 立体定向和功能性神经外科杂志, 2024, 37(4): 235-242.
[2]	杜蓓, 高凯, 刘常权, 刘英彦. 卡莫司汀结合替莫唑胺通过调节生长因子及其受体水平治疗胶质瘤的作用研究[J]. 立体定向和功能性神经外科杂志, 2024, 37(2): 107-115.
[3]	杨利辉, 贾亚男, 宋纪宁, 马克杰, 苏建龙, 宋志俊. 神经内镜辅助下经颞下入路治疗重症脑干出血的临床研究[J]. 立体定向和功能性神经外科杂志, 2024, 37(1): 39-43.
[4]	刘运培, 武银刚, 高歌. 介入栓塞和开颅夹闭治疗WFNS IV级动脉瘤性蛛网膜下腔出血患者的预后分析[J]. 立体定向和功能性神经外科杂志, 2023, 36(5): 274-277.
[5]	王林, 曾明慧, 何芳, 徐昊, 杨涛. 椎板棘突韧带复合体复位技术在椎管肿瘤术中应用的对比性分析(附62例分析)[J]. 立体定向和功能性神经外科杂志, 2023, 36(5): 304-308.
[6]	陈圣典, 许恕, 冯兴隆, 陈义维, 侯仕强. 术前免疫炎症指标CAR联合NLR在基底节区出血手术患者预后中的应用研究[J]. 立体定向和功能性神经外科杂志, 2023, 36(4): 233-236.
[7]	黄弋洋, 李浩, 毛磊, 雷军. 颅内压监测指标预测闭合性颅脑创伤预后的价值[J]. 立体定向和功能性神经外科杂志, 2023, 36(4): 237-241.
[8]	杜云, 王卫中, 刘梦, 姚萌萌. 异柠檬酸脱氢酶1R132H与同源框C10在脑胶质瘤组织的表达及其临床意义[J]. 立体定向和功能性神经外科杂志, 2023, 36(3): 135-140.
[9]	李丛丛, 王献峰, 赵市伟, 胡月龙, 巴永峰, 张超勇. 3Dslicer联合Sina软件辅助神经内镜下微创治疗幕上高血压脑出血的应用研究及其预后影响因素分析[J]. 立体定向和功能性神经外科杂志, 2023, 36(3): 171-177.
[10]	姜海洋, 陈虎, 郭星, 张登文. 血浆Lp-PLA2结合GOS评分评估动脉瘤蛛网膜下腔出血介入治疗预后的价值[J]. 立体定向和功能性神经外科杂志, 2023, 36(2): 100-104.
[11]	宋景辉, 林志坤, 王文浩, 黄巍, 胡康, 罗飞. 可溶性凝集素样氧化性低密度脂蛋白受体1与动脉瘤性蛛网膜下腔出血预后相关性的研究[J]. 立体定向和功能性神经外科杂志, 2023, 36(2): 105-109.
[12]	孟少林, 王伟, 孟凡然, 冯会玉, 何晨曦, 徐伟, 高飞. 基于多模态核磁共振成像脑胶质瘤术后调强适形放疗对患者自主神经反应的影响[J]. 立体定向和功能性神经外科杂志, 2023, 36(1): 22-28.
[13]	范顺志, 程哲, 王大巍, 张辉, 束汉生. 机械取栓治疗大血管闭塞急性缺血性脑卒中预后的多因素分析[J]. 立体定向和功能性神经外科杂志, 2023, 36(1): 42-47.
[14]	陈锋龙, 陈金龙, 张弋. 75岁以上人群破裂颅内动脉瘤栓塞术后早期预后相关因素分析[J]. 立体定向和功能性神经外科杂志, 2022, 35(6): 321-325.
[15]	刘学武, 孙守元, 李富强, 戴志成. 血清褪黑素在动脉瘤性蛛网膜下腔出血预后中的临床意义[J]. 立体定向和功能性神经外科杂志, 2022, 35(6): 326-331.